CSE’s Barrington Miller is joined by Adriana Kertzer, Co-Founder of Plant Medicine Law Group, to discuss the unique aspects of representing clients in the cannabis and psychedelics sectors, ongoing policy and regulation issues, and what makes their law firm different from others in this space. The conversation also highlights Adriana’s thoughts on how she sees the plant medicine landscape evolving.
Here’s an overview of what Barrington and Adriana discuss in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Introducing Adriana Kertzer and Plant Medicine Law Group
4:13 – Client segments across the psychedelic and cannabis industries
7:43 – A diversity of opinions on plant medicine policy
15:40 – Legality and the psychedelic ecosystem
23:49 – Unique differentiators of Plant Medicine Law Group
28:28 – Going public and being part of a larger community
About Plant Medicine Law Group Plant Medicine Law Group expands equitable and legal access to plant medicine by helping companies in the psychedelic and cannabis industries thrive in a complex, emerging market. Their strategic expertise empowers clients to successfully launch, fund and scale their business.
CSE’s Barrington Miller is joined by Anthony Durkacz, Interim CEO of FSD Pharma (CSE:HUGE) to discuss the company’s recent history and transition from the cannabis-era to new opportunities in the growing psychedelics space.
Here’s an overview of what Barrington and Anthony discuss in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Introducing Anthony Durkacz, Interim CEO of FSD Pharma
5:45 – Working back towards a 1Bn market cap
8:10 – The latest investment inLucid Psycheceuticals Inc. and treating MS
10:50 – The psychedelics movement
14:13 – Listing on NASDAQ
About FSD Pharma Inc. FSD Pharma, Inc., is a publicly traded holding company since May 2018.
FSD BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, FSD201, ultra-micronized palmitoylethanolamide (PEA). Ultra-micro PEA is known to target the CB2 receptors of the endocannabinoid system of the human body and acts by down-regulating the pro-inflammatory cytokines to effectuate an anti-inflammatory response.
The company has successfully completed Phase 1 first-in-human safety and tolerability study for FSD201 and has found the compound to be safe with no serious adverse side effects. This study also validated considerable scientific literature already published in the European Union that claims safety and tolerability of micro-PEA. Ultra-micro PEA is currently beings dispensed in Italy and Spain as a prescription based medical food supplement since 2004.
The company received permission from the Food and Drug Administration (FDA) on June 1, 2020 to submit an Investigational New Drug Application (IND) for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.
Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Company is focused on developing FSD201 for its anti-inflammatory properties to avoid the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.
CSE’s Barrington Miller catches up with Timothy Ko, CEO of Entheon Biomedical Corp. (CSE:ENBI) to discuss how his company is pursuing R&D of DMT-based products to safely treat addiction. Timothy provides an update on what the company has accomplished in the year since they’ve been public and upcoming plans for clinical trials.
Here’s an overview of what Barrington and Timothy cover in this edition of the “Exchange for Entrepreneurs” podcast:
0:00 – Catching up with Timothy Ko and Entheon Biomedical
2:30 – What has happened since they listed on the CSE – Canadian Securities Exchange
4:12 – Personalization through genetics
6:20 – The genetics test kit
8:30 – Pathway for clinical trials
9:55 – What’s coming next for investors
About Entheon Biomedical Corp. Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (“DMT Products”) for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
The CSE proudly welcomed Delic Holdings Inc. (CSE:DELC) to a virtual Market Open on November 18th, 2020.
Delic Holdings is a media platform focused on providing information about psychedelics. This media, e-commerce, and event company was formed in 2019 in response to the growing interest in psychedelic science, and it became the first psychedelic umbrella media platform. Delic Holdings’ product offerings and services include a blog, a podcast, an e-commerce store, and periodic events, and they look forward to growing from there.
Several members of the Delic Holdings team joined CEO Jackee Stang as the company opened the day’s trading session in this virtual Market Open.
For more details about the CSE, including information on other Market Opens, please visit theCSE website or follow us on social media.
Could today’s trash be the solution to ending global poverty? Can centennial lifespans become the norm? Will the substances considered criminal today be able to treat and resolve health concerns we see on the rise? The 2019 Extraordinary Future Conference offers attendees the chance to explore the ideas that are shaping the world of tomorrow, and to stay ahead of the curve when it comes to entrepreneurial innovation.
Now in its third year, the Canadian Securities Exchange is proud to once again sponsor the Extraordinary Future conference, which takes place in Vancouver on September 22nd and 23rd. Hosted by Cambridge House International, and featuring talks from thought leaders across a wide spectrum of industries in addition to a diverse lineup of exhibitors, XFuture will help distil the efforts of innovative imaginations and creative changemakers into a cohesive vision of the future.
With over 100 leading public and private technology companies and startups and more than 2,500 attendees expected, this event will be an amazing chance to meet entrepreneurs, business leaders, and investors. And a quick look back at XFuture 2018 proves that there are a lot of reasons to get extraordinarily excited about this year’s event.
Highlights from Extraordinary Future 2018
The speakers at Extraordinary Future 2018 took on some of the most daring topics of the day, including an exploration of the fine line between illegal substances and medical marvels, the explosive growth of eSports, and trailblazing distributed ledger technology that has the potential to evolve the fundamentals of investing.
In a controversial presentation on psychedelics, Hamilton Morris explained the potential applications of psilocybin. Leading a panel discussion on an equally hot topic, Genevieve Roch-Decter of Grit Capital guided a group of entrepreneurs in deconstructing one of the fastest-growing and most talked about market segments: eSports. Exemplifying the entrepreneurial, forward-looking spirit of the conference, CSE CEO Richard Carleton provided insights into the future of finance via tokenized securities, and this was just the beginning of a long list of insightful, eye-opening sessions that happened last year.
Looking Ahead to Extraordinary Future 2019
Life on the bleeding edge of innovation is familiar territory for the Exchange for Entrepreneurs. As with previous shows, this year’s conference will spark discussions about the changes that will revolutionize technology, society, and the economy. From biohacking, to psychedelics to sustainability, here’s a preview of some of the fascinating topics and personalities at this year’s show.
Fitness and health expert, and host of his own podcast, Ben Greenfield will explore the topic of well-being in a high-tech world in his presentation on “The Future of Health: Biohacking and Beyond.” The presentation will explore forward-thinking concepts related to boosting mental and physical performance and extending life.
American ethnopharmacologist, research pharmacognosist, lecturer and author, Dennis McKenna will discuss “From the Plant Medicine Frontier – How Psychedelics like Psilocybin Could Upturn the Mental Health Industry.” This presentation will look into new ways of applying known psychoactive substances that have been controlled, instead of being utilized in the pharmaceutical industry.
Known for the innovative and revolutionary Plastic Bank solution that tackles poverty and ocean pollution simultaneously, David Katz is a dynamic, inspirational speaker described by many as “the best in the sustainability industry.” In an unprecedented move of ingenuity, Katz connected both the need of clean oceans and economic support in impoverished areas into a business that now produces recycled plastic pellets for commercial use. Katz ranks fourth in The World’s Top 100 Compassionate Business Leaders according to Salt Magazine for his entrepreneurial and inventive undertakings, and will be discussing sustainability and innovation in his presentation at the conference.
Looking into the future and constructing his vision of it through active entrepreneurship, Gerard Barron has a record of building globally-focused companies in technology, media and sustainable resource development. As the Chairman and CEO of DeepGreen Metals Inc., Barron is focused on making less-environmentally-disruptive nodule-derived base metals the norm for future automotive construction.
A glimpse of tomorrow can also be caught on the conference floor. With over 50 exhibitors displaying ideas, and products on the leading edge of innovation, this is a great opportunity to see what is driving growth in industries like canntech, eSports, agriculture, digital advertising, and much more. In addition to sponsoring and speaking at this year’s show, the CSE will also be visible on the show floor. Not only will the CSE have its own booth but several CSE-listed firms will also be exhibiting, including BevCanna Enterprises, Lexaria, Rubicon Organics and Bee Vectoring Technology.
New Edition of the Public Entrepreneur Magazine
Another reason to look forward to this year’s show will be the launch of the special Extraordinary Future issue of the CSE’s magazine, Public Entrepreneur. The theme of this issue is also forward-looking and extends the conversation about disruption and innovation by profiling entrepreneurs who are actively doing both in their respective industries. There is also an extra special reason to pick up this next issue as it will feature access to exclusive and groundbreaking content. The #XF2019 edition of Public Entrepreneur magazine will provide a new dimension on digital storytelling that will bring the exciting work of trailblazing entrepreneurs into a whole new light. Be sure to register here to receive your copy when it goes live or pick up an exclusive physical copy at the show itself.
See You in the Future!
Step into the future by joining the CSE, Cambridge House and an exceptional lineup of speakers and entrepreneurs at XFuture 2019. This show offers a unique opportunity to access the ideas, trends and technological innovations that have the potential to shape our future into something extraordinary.
Click here to register to attend the 2019 Extraordinary Future Conference today.